JENNIFER LEIGH MCQUADE to Neoplasms
This is a "connection" page, showing publications JENNIFER LEIGH MCQUADE has written about Neoplasms.
Connection Strength
1.252
-
Eating away cancer: the potential of diet and the microbiome for shaping immunotherapy outcome. Front Immunol. 2024; 15:1409414.
Score: 0.150
-
The Influence of Obesity on Outcomes with Immune Checkpoint Blockade: Clinical Evidence and Potential Biological Mechanisms. Cells. 2023 10 31; 12(21).
Score: 0.144
-
Association of Body Mass Index With the Safety Profile of Nivolumab With or Without Ipilimumab. JAMA Oncol. 2023 01 01; 9(1):102-111.
Score: 0.136
-
Gut Microbiome Modulation Via Fecal Microbiota Transplant to Augment Immunotherapy in Patients with Melanoma or Other Cancers. Curr Oncol Rep. 2020 06 24; 22(7):74.
Score: 0.114
-
Nutrition and Cancer in the Microbiome Era. Trends Cancer. 2019 09; 5(9):521-524.
Score: 0.107
-
Modulating the microbiome to improve therapeutic response in cancer. Lancet Oncol. 2019 02; 20(2):e77-e91.
Score: 0.103
-
Sex as a predictor of response to cancer immunotherapy. Lancet Oncol. 2018 08; 19(8):e376.
Score: 0.100
-
Development of a Strategic Initiative at MD Anderson Cancer Center to Improve Outcomes in Immune-Related Adverse Events. J Natl Compr Canc Netw. 2024 01 08; 22(5).
Score: 0.036
-
Melanoma and microbiota: Current understanding and future directions. Cancer Cell. 2024 01 08; 42(1):16-34.
Score: 0.036
-
Translating energy balance research from the bench to the clinic to the community: Parallel animal-human studies in cancer. CA Cancer J Clin. 2023 Jul-Aug; 73(4):425-442.
Score: 0.034
-
Bodywide ecological interventions on cancer. Nat Med. 2023 01; 29(1):59-74.
Score: 0.034
-
Impact of an Interdisciplinary Goals-of-Care Program Among Medical Inpatients at a Comprehensive Cancer Center During the COVID-19 Pandemic: A Propensity Score Analysis. J Clin Oncol. 2023 01 20; 41(3):579-589.
Score: 0.033
-
Efficacy and safety of vedolizumab and infliximab treatment for immune-mediated diarrhea and colitis in patients with cancer: a two-center observational study. J Immunother Cancer. 2021 11; 9(11).
Score: 0.031
-
Fecal calprotectin concentration to assess endoscopic and histologic remission in patients with cancer with immune-mediated diarrhea and colitis. J Immunother Cancer. 2021 01; 9(1).
Score: 0.030
-
Long-term survival among 5-year survivors of adolescent and young adult cancer. Cancer. 2020 08 15; 126(16):3708-3718.
Score: 0.028
-
Gut Microbiome Modulates Response to Cancer Immunotherapy. Dig Dis Sci. 2020 03; 65(3):885-896.
Score: 0.028
-
Anti-PD-1/PD-L1 immunotherapy in patients with solid organ transplant, HIV?or hepatitis B/C infection. Eur J Cancer. 2018 11; 104:137-144.
Score: 0.025
-
Randomized controlled trial of neurofeedback on chemotherapy-induced peripheral neuropathy: A pilot study. Cancer. 2017 06 01; 123(11):1989-1997.
Score: 0.023
-
Acupuncture for symptom management in cancer care: an update. Curr Oncol Rep. 2014 Dec; 16(12):418.
Score: 0.019
-
Systematic review of acupuncture in cancer care: a synthesis of the evidence. J Clin Oncol. 2013 Mar 01; 31(7):952-60.
Score: 0.017
-
The role of area deprivation index in health care disruptions among cancer survivors during the SARS-CoV-2 pandemic. Public Health. 2024 Jul; 232:52-60.
Score: 0.009
-
Outcomes of Immune Checkpoint Inhibitor-related Diarrhea or Colitis in Cancer Patients With Superimposed Gastrointestinal Infections. Am J Clin Oncol. 2021 08 01; 44(8):402-408.
Score: 0.008
-
Age Correlates with Response to Anti-PD1, Reflecting Age-Related Differences in Intratumoral Effector and Regulatory T-Cell Populations. Clin Cancer Res. 2018 11 01; 24(21):5347-5356.
Score: 0.006